ConductScience.org, home

Paper20965299

A novel adjuvant for vaccine development in the aged.

Morgan EL and 3 others. Vaccine, 2010. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. A novel adjuvant for vaccine development in the aged. Papers, record 20965299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20965299

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel adjuvant for vaccine development in the aged.
PubMed
Journal
Vaccine
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2025-05-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morgan ELEdward L
2Thoman MLMarilyn L
3Sanderson SDSam D
4Phillips JAJoy A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Antigen-Presenting CellsMajor topic
Antigens, FungalMajor topic
Complement C5aMajor topic
OvalbuminMajor topic
Aging
Animals
Coccidioides
Female
Humans
Immunoglobulin G
Interferon-gamma
Interleukin-6
Mice
Mice, Inbred C57BL
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG028077NIA NIH HHSUnited StatesR01AG028077PubMed and NIHNIH RePORTER
R21 AG031496NIA NIH HHSUnited StatesR21AG031496PubMed and NIHNIH RePORTER
AI065712NIAID NIH HHSUnited StatesR21AI065712PubMed and NIHNIH RePORTER
AG028077NIA NIH HHSUnited StatesR01AG028077PubMed and NIHNIH RePORTER
AG031496NIA NIH HHSUnited StatesR21AG031496PubMed and NIHNIH RePORTER
R21 AI065712NIAID NIH HHSUnited StatesR21AI065712PubMed and NIHNIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116552048
Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Infect Immun2006https://conductscience.org/library/papers/16552048PubMed
26690993Correlation between segmental flexibility and effector function of antibodies.Nature1984https://conductscience.org/library/papers/6690993PubMed
311744043Differential effects of ageing on cytokine and chemokine responses during type-1 (mycobacterial) and type-2 (schistosomal) pulmonary granulomatous inflammation in mice.Mech Ageing Dev2002https://conductscience.org/library/papers/11744043PubMed
49620601The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells.Int Immunol1998https://conductscience.org/library/papers/9620601PubMed
519325820Broad-spectrum drugs against viral agents.Int J Mol Sci2008https://conductscience.org/library/papers/19325820PubMed
63426185Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms.Antiviral Res1987https://conductscience.org/library/papers/3426185PubMed
7701803The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice.J Immunol1978https://conductscience.org/library/papers/701803PubMed
817961632Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.Mech Ageing Dev2007https://conductscience.org/library/papers/17961632PubMed
915383582Aged mice develop protective antitumor immune responses with appropriate costimulation.J Immunol2004https://conductscience.org/library/papers/15383582PubMed
1014630877Aging is associated with increased T-cell chemokine expression in C57BL/6 mice.J Gerontol A Biol Sci Med Sci2003https://conductscience.org/library/papers/14630877PubMed
1119008157The effect of aging on T-regulatory cell frequency in HIV infection.Clin Immunol2009https://conductscience.org/library/papers/19008157PubMed
129386344Immunosenescence.Immunol Today1997https://conductscience.org/library/papers/9386344PubMed
1316533888In vivo sites and cellular mechanisms of T reg cell-mediated suppression.J Exp Med2006https://conductscience.org/library/papers/16533888PubMed
1416456016Impaired GATA3-dependent chromatin remodeling and Th2 cell differentiation leading to attenuated allergic airway inflammation in aging mice.J Immunol2006https://conductscience.org/library/papers/16456016PubMed
156965691Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments.J Immunol1980https://conductscience.org/library/papers/6965691PubMed
1619082999Mechanisms of murine dendritic cell antitumor dysfunction in aging.Cancer Immunol Immunother2009https://conductscience.org/library/papers/19082999PubMed
1719540808Vaccination in the elderly: an immunological perspective.Trends Immunol2009https://conductscience.org/library/papers/19540808PubMed
1816198765Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.Lancet2005https://conductscience.org/library/papers/16198765PubMed
1911281848Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations.Curr Med Chem2001https://conductscience.org/library/papers/11281848PubMed
2018495302The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.Vaccine2008https://conductscience.org/library/papers/18495302PubMed

See all 41 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
39771599
Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant Staphylococcus aureus USA300.
Pharmaceutics2024https://conductscience.org/library/papers/39771599PubMed
36145590
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization.
Pharmaceutics2022https://conductscience.org/library/papers/36145590PubMed
33569701The impact of immuno-aging on SARS-CoV-2 vaccine development.Geroscience2021https://conductscience.org/library/papers/33569701PubMed
32233506Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.ACS Infect Dis2020https://conductscience.org/library/papers/32233506PubMed
26111481Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.Clin Immunol2015https://conductscience.org/library/papers/26111481PubMed
24367252Novel strategies to enhance vaccine immunity against coccidioidomycosis.PLoS Pathog2013https://conductscience.org/library/papers/24367252PubMed
24157572Age-dependent dysregulation of innate immunity.Nat Rev Immunol2013https://conductscience.org/library/papers/24157572PubMed
23945157Characterization and optimization of the glucan particle-based vaccine platform.Clin Vaccine Immunol2013https://conductscience.org/library/papers/23945157PubMed
23785433Immunization of aged pigs with attenuated pseudorabies virus vaccine combined with CpG oligodeoxynucleotide restores defective Th1 immune responses.PLoS One2013https://conductscience.org/library/papers/23785433PubMed
23585916Progress Toward a Human Vaccine Against Coccidioidomycosis.Curr Fungal Infect Rep2012https://conductscience.org/library/papers/23585916PubMed
23365077Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections.J Immunol2013https://conductscience.org/library/papers/23365077PubMed
22792270Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.PLoS One2012https://conductscience.org/library/papers/22792270PubMed
22575167An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.Vaccine2012https://conductscience.org/library/papers/22575167PubMed
22044742Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.Vaccine2011https://conductscience.org/library/papers/22044742PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20965299

GET https://conductscience.org/api/papers/v1/20965299/references?page=2